Peapack-Gladstone Financial Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$71.1M Sell
77,353
-1,607
-2% -$1.63M 0.91% 22
2025
Q4
$84.9M Sell
78,960
-1,902
-2% -$1.82M 1.07% 17
2025
Q3
$61.7M Buy
80,862
+1,466
+2% +$1.09M 0.8% 30
2025
Q2
$61.9M Buy
79,396
+3,410
+4% +$2.65M 0.88% 27
2025
Q1
$62.8M Buy
75,986
+1,867
+3% +$1.55M 0.93% 24
2024
Q4
$57.2M Buy
74,119
+492
+0.7% +$407K 0.83% 29
2024
Q3
$65.2M Sell
73,627
-3,315
-4% -$2.98M 0.94% 23
2024
Q2
$69.7M Sell
76,942
-215
-0.3% -$172K 1.07% 15
2024
Q1
$60M Sell
77,157
-959
-1% -$682K 0.94% 23
2023
Q4
$45.5M Sell
78,116
-3,632
-4% -$2.12M 0.77% 29
2023
Q3
$43.9M Sell
81,748
-421
-0.5% -$217K 0.81% 25
2023
Q2
$38.5M Sell
82,169
-5,627
-6% -$2.36M 0.69% 32
2023
Q1
$30.5M Sell
87,796
-4,129
-4% -$1.39M 0.58% 45
2022
Q4
$33.6M Sell
91,925
-1,543
-2% -$547K 0.66% 39
2022
Q3
$30.2M Buy
93,468
+17,495
+23% +$5.54M 0.62% 43
2022
Q2
$24.6M Sell
75,973
-1,485
-2% -$446K 0.56% 53
2022
Q1
$22.2M Sell
77,458
-1,903
-2% -$490K 0.43% 67
2021
Q4
$21.9M Buy
79,361
+7,350
+10% +$1.86M 0.41% 69
2021
Q3
$16.6M Sell
72,011
-2,005
-3% -$495K 0.34% 79
2021
Q2
$17M Sell
74,016
-1,115
-1% -$224K 0.41% 73
2021
Q1
$14M Buy
75,131
+4,419
+6% +$864K 0.36% 81
2020
Q4
$11.9M Buy
70,712
+4,515
+7% +$674K 0.36% 82
2020
Q3
$9.8M Sell
66,197
-7,622
-10% -$1.18M 0.36% 81
2020
Q2
$12.1M Sell
73,819
-2,180
-3% -$335K 0.48% 61
2020
Q1
$10.5M Sell
75,999
-4,476
-6% -$615K 0.5% 61
2019
Q4
$10.6M Sell
80,475
-3,190
-4% -$370K 0.43% 70
2019
Q3
$9.36M Sell
83,665
-1,400
-2% -$156K 0.4% 74
2019
Q2
$9.43M Sell
85,065
-221
-0.3% -$26K 0.41% 75
2019
Q1
$11.1M Sell
85,286
-66
-0.1% -$8.03K 0.5% 62
2018
Q4
$9.88M Sell
85,352
-679
-0.8% -$75.8K 0.51% 62
2018
Q3
$9.23M Buy
86,031
+9,036
+12% +$903K 0.45% 73
2018
Q2
$6.57M Buy
76,995
+7,185
+10% +$590K 0.34% 87
2018
Q1
$5.4M Buy
69,810
+1,921
+3% +$155K 0.29% 95
2017
Q4
$5.73M Buy
67,889
+4,264
+7% +$363K 0.31% 92
2017
Q3
$5.44M Buy
63,625
+2,515
+4% +$206K 0.31% 89
2017
Q2
$5.03M Buy
61,110
+2,292
+4% +$187K 0.3% 92
2017
Q1
$4.95M Buy
58,818
+1,102
+2% +$88.3K 0.3% 90
2016
Q4
$4.25M Buy
57,716
+4,171
+8% +$311K 0.28% 95
2016
Q3
$4.3M Buy
53,545
+135
+0.3% +$10.8K 0.29% 95
2016
Q2
$4.21M Sell
53,410
-2,259
-4% -$170K 0.29% 95
2016
Q1
$4.01M Sell
55,669
-3,085
-5% -$233K 0.28% 96
2015
Q4
$4.95M Sell
58,754
-5,040
-8% -$418K 0.35% 88
2015
Q3
$5.34M Sell
63,794
-2,924
-4% -$247K 0.4% 81
2015
Q2
$5.57M Sell
66,718
-1,300
-2% -$99.1K 0.39% 79
2015
Q1
$4.94M Buy
68,018
+638
+0.9% +$45.4K 0.34% 85
2014
Q4
$4.65M Sell
67,380
-140
-0.2% -$9.45K 0.33% 87
2014
Q3
$4.38M Buy
67,520
+1,635
+2% +$104K 0.33% 88
2014
Q2
$4.1M Buy
65,885
+1,910
+3% +$114K 0.31% 90
2014
Q1
$3.77M Sell
63,975
-1,968
-3% -$110K 0.3% 95
2013
Q4
$3.36M Sell
65,943
-672
-1% -$33.7K 0.27% 97
2013
Q3
$3.35M Sell
66,615
-2,365
-3% -$124K 0.29% 90
2013
Q2
$3.39M Buy
+68,980
New +$3.75M 0.31% 84

Other funds holding LLY

Peapack-Gladstone Financial Corp's LLY Position: Q1 2026 in Review

Peapack-Gladstone Financial Corp reduced its Eli Lilly (LLY) stake by 2% in Q1 2026, selling an estimated $1.63M and leaving 77,353 shares worth $71.1M. The position accounts for 0.91% of the portfolio, ranked #22.

Peapack-Gladstone Financial Corp first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $84.9M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Peapack-Gladstone Financial Corp held 77,353 shares of Eli Lilly worth $71.1M as of Q1 2026.
  • Peapack-Gladstone Financial Corp sold 1,607 Eli Lilly shares in Q1 2026, an estimated $1.63M.
  • Eli Lilly made up 0.91% of Peapack-Gladstone Financial Corp's portfolio in Q1 2026, its #22 holding.
  • Peapack-Gladstone Financial Corp first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Peapack-Gladstone Financial Corp's Eli Lilly position peaked at $84.9M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q1 2026, filed 15 May 2026.